IBNSINA PHARMA CO SAE EGX:ISPH:
IBNSINA PHARMA Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 271 MILLION
IBNSINA PHARMA Q3 CONSOL NET SALES EGP 20.35 BILLION
Ibnsina Pharma Q3 Consol Profit EGP 271 Million
Earlier from Ibnsina Pharma
- SNG: Ibnsina Pharma leads non-pharma product distribution in Egyptian pharmacies in 9 months
- SNG: Egypt: Ibnsina Pharma to disburse $0.0033/share cash dividend in October
- Ibnsina Pharma FY Dividend Per Share EGP 0.16
- SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025